Closed, pending review.

Letters of Intent (RE03) were due April 15, 2021 (Separate Application)

LOI acceptance notifications: May 3rd, 2021

Upon LOI acceptance, Research Grant Application Due: June 8th, 2021

Funding Level: $50,000 over 2 years

Funding Available: August/September 2021

Purpose of Grant: To support rigorous scientific oncology nursing research. Research projects may include investigator-initiated research, pilot or feasibility studies, supplements to current funded projects, or developing a new aspect of a program of research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically based oncology practice. Competitive applications will addresses the ONS Research Agenda See "Research Agenda of the Oncology Nursing Society: 2019-2022," published in the Oncology Nursing Forum, November 2019, Volume 46, No. 6.
The following three (3) key areas in need of oncology nursing research articulated in the ONS Research Agenda are:
     • Symptom Science in Immunotherapy and Emerging Therapies in Precision Health and Biosignatures
     • Health Disparities
     • Palliative and Psychosocial Oncology Care

Eligibility:  The principal investigator (individual primarily responsible for implementing the proposal and reporting to Oncology Nursing Foundation) must be a registered nurse actively involved in some aspect of cancer patient care, education, or research and be PhD or DNSc prepared (only one PI can appear on the grant). *At least one member of the research team must have received and completed research study funding of at least $100,000 as PI.

Closed, applicants notfied.

Letter of Intent (RE42) was due: May 17, 2021 

Upon LOI acceptance, Grant Application (RE42) Due: July 15, 2021

Purpose: To support oncology nursing research addressing cancer health disparities, including in the topic areas of breast, colorectal, lung or prostate cancer.

Funds: Grant up to $100,000 will be awarded with funding period of up to two years. 

Eligibility: The principal investigator must be a registered nurse actively involved in some aspect of cancer patient care, education or research and be PhD or DNSc prepared that has received and completed at least one research study of at least $50,000 as PI. Membership in ONS is not required.

Research funding awarded under this grant program is in part generously supported by a grant to the Oncology Nursing Foundation from Merck.

Closed.

Letter of Intent (RE43) was due: May 17, 2021

Upon LOI acceptance, Grant Application (RE43) Due: July 15, 2021

Purpose: To support oncology nursing research in symptom science addressing the adverse effects of immunotherapy and emerging therapies used in the treatment of cancer patients. Symptom Science in immunotherapy and emerging therapies has been identified as one of the top cancer nursing research priorities in need of new knowledge.

Funds: Grant up to $150,000 will be awarded with funding period of up to two years.

Eligibility: The principal investigator must be a registered nurse actively involved in some aspect of cancer patient care, education or research and be PhD or DNSc prepared that has received and completed at least one research study of at least $50,000 as PI. Membership in ONS is not required.

Research funding awarded under this grant program is in part generously supported by a grant to the Oncology Nursing Foundation from Bristol Myers Squibb.